AI-Driven Transcriptome Prediction in Human Pathology: From Molecular Insights to Clinical Applications
Biology · 04.06.2025 · 14 (6) · 651
DOI: 10.3390/biology14060651 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 04.06.2025. Verfasst von Xiaoya Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: BGI Research, Hangzhou 310030, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Gene expression regulation underpins cellular function and disease progression, yet its complexity and the limitations of conventional detection methods hinder clinical translation. In this review, we define “predict” as the AI-driven inference of gene expression levels and regulatory mechanisms from non-invasive multimodal data (e.g., histopathology images, genomic sequences, and electronic health records) instead of direct molecular assays. We systematically examine and analyze the current approaches for predicting gene expression and diagnosing diseases, highlighting their respective advantages and limitations. Machine learning algorithms and deep learning models excel in extracting meaningful features from diverse biomedical modalities, enabling tools like PathChat and Prov-GigaPath to improve cancer subtyping, therapy response prediction, and biomarker discovery. Despite significant progress, persistent challenges—such as data heterogeneity, noise, and ethical issues including privacy and algorithmic bias—still limit broad clinical adoption. Emerging solutions like cross-modal pretraining frameworks, federated learning, and fairness-aware model design aim to overcome these barriers. Case studies in precision oncology illustrate AI’s ability to decode tumor ecosystems and predict treatment outcomes. By harmonizing multimodal data and advancing ethical AI practices, this field holds immense potential to propel personalized medicine forward, although further innovation is needed to address the issues of scalability, interpretability, and equitable deployment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BGI Research, Hangzhou 310030, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
- Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
- College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.
- State Key Laboratory of Genome and Multi-Omics Technologies, BGI Research, Shenzhen 518083, China.
- Key Laboratory of the Ministry of Education for Mathematical Foundations and Applications of Digital Technology, University of Science and Technology of China, Hefei 230027, China.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, X., Xu, H., Yu, S., Hu, W., Zhang, Z., Wang, X., Yuan, Y., Wang, M., Chen, L., Lin, X., Hu, Y., & Cai, P. (2025). AI-Driven Transcriptome Prediction in Human Pathology: From Molecular Insights to Clinical Applications. Biology, 14(6), 651. https://doi.org/10.3390/biology14060651
Vancouver
Chen X, Xu H, Yu S, Hu W, Zhang Z, Wang X, et al. AI-Driven Transcriptome Prediction in Human Pathology: From Molecular Insights to Clinical Applications. Biology. 2025;14(6):651. doi:10.3390/biology14060651
BibTeX
@article{Chen2025,
author = {Chen, Xiaoya and Xu, Huinan and Yu, Shengjie and Hu, Wan and Zhang, Zhongjin and Wang, Xue and Yuan, Yue and Wang, Mingyue and Chen, Liang and Lin, Xiumei and Hu, Yinlei and Cai, Pengfei},
title = {AI-Driven Transcriptome Prediction in Human Pathology: From Molecular Insights to Clinical Applications},
journal = {Biology},
year = {2025},
volume = {14},
number = {6},
pages = {651},
doi = {10.3390/biology14060651}
}
EUVIMED